Your decision, not a generic summary.
A small biotech may have enough evidence to be interested but not enough to choose between another assay, an analysis of existing data or an asset option. Karam’s proposed scopes begin with that choice. The useful deliverable is a decision and its source trail—not an expanding pile of summaries.
Where a scoped engagement can help.
Before a new experiment
Use a bounded evidence question to identify what the experiment must resolve and what result would change the plan.
After an ambiguous dataset
Inspect the data and analysis before assuming another study is the best use of the budget.
When using an external laboratory
Compare complete vendor scopes, repeat rules and data rights rather than headline prices.
What to bring.
Your decision deadline, nonconfidential evidence summary, budget range and the smallest authorized example needed to assess feasibility.
How to compare a proposal.
Ask any provider who reviews the work, exactly what is delivered, what makes it acceptable and which activities are excluded. For Karam, staff qualification and a confirmed delivery slot come before a contract.
Example inquiry: “We have a decision in six weeks. Should we validate this reported cell-state effect, reanalyze our existing dataset, or stop?”